(Bloomberg) — Sanofi said the rheumatoid arthritis medicine Kevzara failed to work against the new coronavirus, joining a growing list of treatments that were tried and discarded in the pandemic.The drug, which stoked hope against Covid-19 because it works on inflammation, didn’t significantly shorten patients’ hospital stays in a study involving 420 people, Sanofi said in a statement Tuesday. Patients were about as likely to develop severe infections such as pneumonia and die on Kevzara as they were on a placebo.Doctors and drugmakers are scouring labs for existing treatments — from antiviral drugs to plasma from recovered patients — that …read more
Source:: Yahoo Finance
